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ABSTRACT
Ring Y chromosome is a very rare chromosomal 
aberration. The published mixed gonadal dysgenesis 
(MGD) patients with a ring Y chromosome are short 
in stature, but are not growth hormone (GH) deficient. 
We present the molecular cytogenetic and molecular 
characterization of ring Y chromosome mosaicism in a 
10-year-old boy with MGD whose short stature could 
be explained by the high percentage of cells mono-
somic for the X-chromosome, but also by the presence 
of severe GH deficiency. The ring Y chromosome in 
our patient is a de novo structural aberration. The fa-
ther’s karyotype was normal.
Key words: Growth hormone (GH) deficiency; 
Mixed gonadal dysgenesis (MGD); Mosaicism; Ring 
Y chromosome.
INTRODUCTION
The frequency of ring chromosomes in clini-
cally detectable conceptions is 1/25,000 [1]. Several 
mechanisms have been proposed for the formation of 
ring chromosomes [2-4]. The most likely mechanism 
for their formation involves terminal breakage in both 
chromosome arms and fusion of the remaining ends 
and loss of deleted distal material. Because of the in-
stability of ring chromosomes during mitosis, a second 
monosomic cell line is often present in these patients 
[4]. Most patients present a mosaic 45,X/46,X,r(Y) 
karyotype, with phenotypes ranging from female in-
dividuals with streak gonads to male patients with 
bilateral dysgenetic testes, mixed gonadal dysgenesis 
(MGD) or infertility as the only presentation [2,3,5-
13]. Variability of phenotype depends on the percent-
age of monosomic cells and on the genetic material 
deleted during the formation of ring Y chromosome. 
There are few published reports in which ring the Y 
chromosome is directly associated with a MGD, but 
only exceptionally has the ring chromosome been ana-
lyzed by molecular techniques. These published MGD 
patients with a ring Y chromosome had short stature, 
but none of them had growth hormone (GH) deficiency 
[2,12]. Here, we present the molecular cytogenetic and 
molecular characterization of a ring Y chromosome 
mosaicism in a 10-year-old boy with MGD, short stat-
ure and GH deficiency.
MATERIALS AND METHODS
Clinical Report. A 10-year-old boy of healthy 
and unrelated parents was referred for evaluation of 
perineal hypospadias and unilateral cryptorchidism, 
anomalies that were incompletely surgically corrected 
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in early childhood in a regional hospital. He was the 
second child in the family, born at term after a normal 
pregnancy and delivery: birth weight was 2850 g and 
length 49 cm. His motor and mental development was 
normal. He was obese from early childhood. On ad-
mission to our hospital, his height was 129.3 cm (3rd-
10th centile), but inconsistent for the target height of 
173.5 cm (25th-50th centile). His weight was 53.6 
kg, body mass index (BMI) was 32.99 kg/m2 (>97th 
centile) and he had significant acanthosis nigricans on 
the neck, in the axillae and the cubital area. Bilateral 
pseudogynecomastia was also noticed. His external 
genitalia appeared predominantly male, his penis was 
4.5 cm, and showed scars from previous operations. 
The large scrotal sac contained a 4 ml testis on the left, 
and an irregular mass of 0.5 ml on the right.
Basal gonadotrophin levels were: luteinizing hor-
mone (LH) 0.1 IU/L (0.03-0.43 IU/L), follicle-stimulat-
ing hormone (FSH) 1.7 IU/L (0.22-1.92 IU/L) and tes-
tosterone 0.1 nmol/L (0.06-0.8 nmol/L). Testosterone 
response to a short human chorionic gonadotrophine 
(HCG) test showed 1.2 and 2.6 nmol/L on days 3 and 4, 
respectively. Peak value of GH in the clonidine test was 
1.2 mIU/Ll (>20 mIU/L), while values during overnight 
profile of GH were as follows: for peak value 1.1 mIU/L 
(>13.1 mIU/L) and for mean value 0.23 mIU/L (>3.2 
mIU/L). The level of insulin-like growth factor-1 (IGF-
1) was 164 ng/mL (88-452 ng/mL) and IGF binding 
protein-3 (IGFBP-3) was 4.9 µg/mL (2.1-7.7 µg/mL). 
Serum free thyroxine and thyroid-stimulating hormone 
were normal. An oral glucose tolerance test showed 
no glucose intolerance but the insulin levels peaked at 
656.8 mIU/L (100 mIUL/L). The homeostasis model 
assessment of insulin resistance (HOMA-IR) was 6.6 
(3.16). Levels of high density lipoprotein cholesterol 
(HDL-c), low-density lipoprotein cholesterorl (LDL-c) 
and triglycerides were normal. Bone age was estimated 
at 12 years. Magnetic resonance imaging (MRI) of the 
brain did not reveal any structural abnormality in the 
hypothalamic-pituitary region. Histopathology of sur-
gical biopsy of the left gonad confirmed the presence 
of normal testicular tissue with early spermatogenesis. 
The irregular mass from the right side of the scrotal sac 
was histopathologically described as a streak gonad 
with the presence of a Fallopian tube and rudimentary 
uterus. Growth hormone therapy, 1.0 mg/m2/day, was 
started. During the first year of treatment his height in-
creased by 11.0 cm and reached the 25th centile. He 
remained extremely obese.
Cytogenetic and Molecular Cytogenetic Stud-
ies. Cytogenetic analysis was performed on G-banded 
metaphase chromosomes obtained from cultures of 
PHA-stimulated blood lymphocytes from the proband 
and his parents according to standard procedures 
[14,15]. Fluorescence in situ hybridization (FISH) was 
performed on peripheral blood lymphocytes using a Y 
chromosome cen satellite probe (Q-Biogene, Carlsbad, 
CA, USA) to detect and enumerate the Y chromosome-
specific DYZ3 locus, according to the manufacturer’s 
recommendations, using an Axioskop microscope and 
MC 80 camera (Carl Zeiss, Jena, Germany). Subcen-
tromere-specific multicolor FISH (subcenM-FISH) 
was performed using RP11-115H13, RP11.71M14 and 
a centromeric probe for the Y chromosome, as reported 
previously [16]. Fluorescent in situ hybridization with 
a subtelomeric TELVysion Xp/Yp probe, spectrum 
green (Abbott Laboratories, Abbott Park, IL, USA) 
and CEPY (DYZ1) probe for Yq12 (Abbott Laborato-
ries) were used for precise characterization of the ring 
Y chromosome. The FISH images were captured on a 
Zeiss Axioplan microscope (Zeiss) with the IKAROS 
and ISIS digital FISH imaging system (MetaSystems, 
Altlussheim, Germany). Telomeric FISH (Telo-FISH) 
was performed as described in [17], using the Cy-3 la-
beled telomeric PNA probe (CCCTAA) 3 and staining 
with DAPI-mounting medium (Vector Laboratories). 
Chromosomal analysis was performed using a Zeiss-
Axioimager A1 microscope equipped with a CCD cam-
era and Axiocam image acquisition software (Imaging 
Associate) and software, Image J. Fifteen metaphases 
were analyzed for the presence of telomeric signals.
Molecular Genetic Studies. Genomic DNA was 
extracted from a peripheral blood sample by standard 
procedures [18]. The heterochromatic region of the Y 
chromosome was analyzed using polymerase chain re-
action (PCR) with primers flanking part of a Y chro-
mosome-specific region (the repetitive 3.4 kb sequence 
from the DYZ1 family) [19]. Diagnostic testing of Y 
chromosome-specific microdeletions was performed 
using multiplex PCR amplification directed against 
three distinct azoospermia (AZF) regions [AZFa (s84, 
s86), AZFb (s127, s134) and AZFc (s254, s255)] on 
the long arm of the Y chromosome, the SRY gene on 
the short arm of the Y chromosome, and the ZFX/ZFY 
gene as an internal control [20]. Positive and nega-
tive controls were provided by DNA samples from a 
man with normal spermatogenesis and from a healthy 
woman, respectively.
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RESULTS
Karyotype analysis of G-banded lymphocyte chro-
mosomes revealed a 45,X karyotype in 24/44 (54.5%) 
cells, a normal number of chromosomes with a small, 
dot-like ring chromosome in 17/44 (38.6%) cells, and 
47 chromosomes with two ring chromosomes (Figure 
1A and 1B) in 3/44 (6.8%) cells. We considered the 
small ring chromosome to have originated from the 
Y chromosome and described the patient’s karyotype 
as: mos 45,X[24]/46,X, r(?Y)[17]/47,X, r(?Y)x2[3]. 
Parental karyotypes were normal. The C-banding 
analysis of the heterochromatic Yqh region of the pa-
tient and his father showed the loss of this region in 
the patient and its presence in the father, suggesting a 
de novo origin of the ring chromosome. Fluorescent in 
situ hybridization using a Y chromosome centromeric 
α satellite probe demonstrated the absence of a fluo-
rescent signal in 31/100 cells and the presence of one 
(19/100) and two (2/100) fluorescent signals in inter-
phase nuclei and metaphase cells (Figure 1C and 1D). 
When a Y chromosome centromeric α satellite probe 
was used, one fluorescent signal was found on the ring 
Y chromosome, confirming its monocentric nature. 
The somatic karyotype was therefore described as: 
45,X[31]/46,X.ishr(Y) (DYZ1+) [19]/ 47,X.ish r(Y)
x2(DYZ1x2)[2].
SubcenM-FISH [25] characterized two ring (Y) 
variants in the patient’s karyotype: ish r(Y)(RP11-
115H13+, cepY+,RP11.71M14+) and ishr(Y;Y)(RP11-
115H13++, cepY++,RP11.71M14++) (Figure 2A). 
These were present in different combinations in at least 
three cellular subpopulations: 46,X,r(Y);47,X,r(Y)x2; 
47,X,r(Y)+r(Y;Y). The additional ring (Y;Y) variant, 
found in only one cell, was a ring chromosome in the 
process of forming a double ring.
Telo-FISH displayed an r(Y) chromosome with 
no telomeric signals (Figure 2C), thus confirming loss 
of telomeric regions on Yp and Yq. Fluorescent in situ 
hybridization with the subtelomeric probe Xp/Yp and 
probe for Yq12, demonstrated the presence of the Yp 
subtelomeres and deletion of Yq12 region on the r(Y). 
The double Y chromosome r(Y;Y) showed two signals 
for the Yp subtelomere region (Figure 2B).
Polymerase chain reaction with primers for the 
heterochromatic region of the Y chromosome revealed 
that the whole of this Yq12 region was missing. Mul-
tiplex PCR with selected primers for AZF (the AZFa, 
AZFb and AZFc) region, SRY and ZFY/ZFX genes 
showed their presence (Figure 3). These results con-
firmed the presence of two breakpoints on the Y chro-
mosome that led to formation of the ring: one on the 
Yp arm (between the subtelomeric region and the te-
lomere) and the other on the Yq arm at Yq12.
Figure 1. (A-B) G-Banded partial karyotype showing one 
and two ring Y chromosomes (arrow). (C-D) 
The FISH analysis with a Y-centromere satellite 
probe DYZ3 demonstrating one and two signals 
on metaphase chromosomes.
Figure 2. (A) SubcenM-FISH with probe set for the Y chro-
mosome: ring [r(Y)] and double ring [r(Y;Y)] 
are shown on the left part of the figure. A scheme 
showing a normal Y chromosome and the probes 
applied is depicted on the right. (B) The FISH anal-
ysis with subtelomeric Xp/Yp probe and probe for 
the Yq12 region demonstrates the presence of two 
signals on the double ring [r(Y;Y)] (arrow) and 
one signal on the normal X chromosome; the Yq12 
signal is not present. (C) Telo-FISH displayed r(Y) 
chromosome with no telomeric signals (arrow).
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DISCUSSION
We present a male patient with MGD and a mosaic 
karyotype with a high percentage of monosomic 45,X 
cell line and two ring (Y) variants presented in differ-
ent combinations within at least three cellular subpop-
ulations. Cytogenetic, molecular cytogenetic and mo-
lecular analyses demonstrated that the two breakpoints 
on the Y chromosome were localized on the Yp arm 
(between the subtelomeric region and the telomere) 
and the Yq arm at Yq12 (the AZF region was present), 
respectively, leading to fusion of the broken ends and 
loss of genetic material. As the father’s karyotype is 
normal, ring formation occurred de novo in this pa-
tient. The presence of two ring (Y) variants, monocen-
tric ring Y and dicentric ring (Y;Y), could result from 
the specific behavior of the ring chromosome during 
mitosis depending on the number of sister chromatid 
exchanges (SCEs). These SCEs could result in the for-
mation of dicentric Y chromosomes, which would then 
undergo unequal partition during successive mitotic 
divisions inducing the formation of rings of different 
sizes [4,21]. Non disjunction could produce a general 
increase in the number of rings in different cellular 
populations, as was the case in our patient.
The high percentage of the monosomic 45,X cell 
line in our patient, due to the instability of the ring 
chromosome during mitosis, could explain his short 
stature. The presence of subtelomere Yp signal on the 
r(Y) chromosome suggests that the genetic material 
loss implicated in ring Y formation did not include the 
SHOX/PHOG gene, which is localized in the PAR1 
region [4,21,22]. Molecular analysis showed the pres-
ence of the SRY gene. The dicentric ring (Y;Y) found 
in one cell suggests the presence of a cell line with 
two copies of SRY. More cells carrying the SRY gene 
result in more testicular structures and increased vi-
rilization due to higher production of testosterone by 
Leydig cells [2]. Bettio et al. [23] indicated that pheno-
Figure 3. Polymerase chain reaction analysis. (A) Analy-
ses of Y microdeletions (multiplex A and B); (B) 
detection of Y heterochromatin region; lanes 1 
and 6 (A) and 2 and 3 (B): the proband; lanes 2 
and 7 (A) and 4 (B): female control; lanes 3 and 
8 (A) and 5 (B): male control; lanes 5 (A) and 1 
(B): 1 kb DNA ladder.
Table 1. Clinical features of patients with a ring Y chromosome and mixed gonadal dysgenesis.
Parameters Our Patient Patient in [12] Patient in [3]
Sex-Age M-10 M-12 F-infant
External genitalia Hypospadia, unilateral
cryptorchidism
Hypospadia, unilateral
cryptorchidism
3 × 1 cm phallic structure,
perineal urethral opening,
bifid scrotum, single
urogenital opening
Karyotype from
peripheral blood
45,X/46,X,r(Y)/47,X,r(Y)
x2/47,X,r(Y)+r(Y;Y)
45,X/46,X,r(Y)/47,X,r(Y)
x2/48,X,r(Y)x3/49,X,r(Y)x4
45,X/46,X,r(Y) (di-, tetra-,
octacentric)
Monosomic cells in
peripheral blood
55.0% 7.0% 81.0%
Molecular analysis SRY + AZF(a, b, c) +
telomeres - subtelomeric
region: p+ q-
SRY + (not in all ring Y
chromosomes)
SRY +
Father’s karyotype 46,XY 46,XYqh+ No data
Patient height 5-10th centile 10th centile No data
Growth hormone
deficiency
Yes No data No data
Obesity and acanthosis
nigricans
Yes (weight: >97th centile) Yes (weight: 90th centile) No data
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typic sex is determined by the presence of the 45,X vs. 
SRY-bearing cells and depends more on the number of 
copies of the SRY gene rather than on the percentage of 
45,X cells, at least in the gonads. The degree of mosa-
icism varies between tissues, and a mosaic karyotype 
is often associated with MGD [24].
Molecular analysis showed the presence of AZF 
(AZFa, AZFb, AZFc), SRY and ZFY/ZFX genes that 
correlated with the pathological findings at testis bi-
opsy, which revealed testicular tissue with initial sper-
matogenesis. Also, there was a normal testosterone 
response to a short HCG test.
According to the literature, the association of 
mixed gonadal dysgenesis and ring Y chromosome 
is extremely rare [2,12]. Our patient is the third pa-
tient with such abnormalities to be described in the 
literature. All patients have been short for their target 
height, but the two previous cases were not reported 
to have GH deficiency (Table 1). In our patient, the 
diagnosis of severe GH deficiency was established ac-
cording to results of clonidine test as well as results of 
overnight profile of GH. Thus, he is the first reported 
case of gonadal dysgenesis associated with a ring Y 
chromosome whose short stature could be explained 
not only by the presence of a high percentage of mono-
somic cells, but also by GH deficiency. The first-year 
response to GH treatment with a standard dose of GH 
was successful. Normal levels of IGF-1 and IGFBP-3 
could be explained by obesity, insulin resistance and 
hyperinsulinemia [25].
As with one patient reported previously [12], our 
patient was obese with significant acanthosis nigricans 
and pseudogynecomastia. His obesity was secondary 
to excessive food intake, consistent with the family’s 
overall nutrition. Insulin resistance and acanthosis 
nigricans could be explaines as a common finding in 
obese children, as well as his advanced bone age. The 
obesity and acanthosis persisted after 1 year of GH 
therapy suggesting that the obesity at presentation was 
not a consequence of hypopituitarism.
Although short stature in patients with MGD as-
sociated with ring Y chromosomes can almost always 
be explained as a consequence of the high percentage 
of monosomic cells, or loss of SHOX and other genes 
important for growth, test for GH secretion should be 
performed in each child with impaired growth. Further 
studies are necessary to define the importance of pro-
vocative tests and/or overnight profile of GH in short 
patients with MGD.
REFERENCES
1. Jacobs PA. Mutation rates of structural chromosome 
rearrangements in man. Am J Hum Genet. 1981; 33(1): 
44-54.
2. Henegariu O, Kernek S, Keating MA, Palmer CG, 
Heerema NA. PCR and FISH analysis of a ring Y chro-
mosome. Am J Med Genet. 1997; 69(2): 171-176.
3. Henegariu O, Pescovitz OH, Vance GH, Verbrugge J, 
Heerema NA. A case with mosaic di-, tetra-, and octa-
centric ring Y chromosomes. Am J Med Genet. 1997; 
71(4): 426–429.
4. Miller OJ, Therman E. Human Chromosomes. New 
York: Springer Verlag, 2001.
5. Hsu LY. Phenotype/karyotype correlations of Y chro-
mosome aneuploidy with emphasis in structural aberra-
tions in postnatally diagnosed cases. Am J Med Genet. 
1994; 53(2): 108-140.
6. Sher ES, Addelston MB, Plotnick L, Urban MD, Berko-
vitz GD. Molecular investigation of two male subjects 
with short stature and a 45,X/46,X,ring(Y) karyotype. 
Horm Res. 1998; 49(1): 46-50.
7. Tanaka M, Ohmizono Y. Short stature and Turner skel-
etal features in an 11-year-old boy with a ring Y chro-
mosome missing the short stature homeobox containing 
gene. Clin Pediatr Endocrinol. 2005; 14(2): 45-47.
8. Carvalho FM, Wolfgramm EV, Degasperi I, Verbeno 
BM, Vianna BA, Chagas FF, Perroni AMS, Paula F, 
Louro ID. Molecular cytogenetic analysis of a ring Y in-
fertile male patient. Genet Mol Res. 2007; 6(1): 59-66.
9. Layman LC, Tho SPT, Clark AD, Kulharya A, Mc-
Donough PG. Phenotypic spectrum of 45,X/46,XY 
males with a ring Y chromosome and bilaterally de-
scended testes. Fertil Steril. 2009; 91(3): 791-797.
10. Liehr T, Mrasek K, Hinreiner S, Reich D, Ewers E, 
Bartels I, Seidel J, Emmanuil M, Petersen M, Polityko 
A, Dufke A, Iourov I, Trifonov V, Vermeesch J, Weise 
A. Small supernumerary marker chromosomes (sSMC) 
in patients with a karyotype 45,X/46,X,+mar – 17 new 
cases and a review of the literature. Sex Dev. 2007; 
1(1): 353-362.
11. Liehr, T. Homepage on small supernumerary marker 
chromosomes (sSMC). http://www.med.uni-jena. de/
fish/sSMC/ 00START.htm (Accessed March 15, 2011).
12. Lopez-Valdes JA, Nieto K, Najera N, Cervantes A, 
Kofman-Alfaro S, Queipo G. Mix gonadal dysgenesis 
associated with ring Y chromosome mosaics in a phe-
notypic male. Sex Dev. 2009; 3(4): 177-182.
13. Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus 
statement on management of intersex disorders. Pediat-
rics. 2006; 118(2): 488-500.
14. Moorhead PS, Nowell PC, Mellman WJ, Battips DM, 
Hungerford DA. Chromosome preparation of leuko-
cytes cultured from human peripheral blood. Exp Cell 
Res. 1960; 20: 613-616.
Unauthenticated
Download Date | 3/8/18 2:36 PM
76
RING Y CHROMOSOME, MGD AND GH DEFICIENCY
15. Seabright M. A rapid banding technique for human 
chromosomes. Lancet. 1971; 2(7731): 971-972.
16. Starke H, Nietzel A, Weise A, Heller A, Mrasek K, 
Belitz B, Kelbova C, Volleth M, Albrecht B, Mitulla 
B, Trappe R, Bartels I, Adilph S, Dufke A, Singer S, 
Stumm M, Wegner RD, Seidel J, Schmidt A, Kuechler 
A, Schreyer I, Claussen U, von Eggeling F, Liehr T. 
Small supernumerary marker chromosomes (SMCs): 
genotype-phenotype correlation and classification. 
Hum Genet. 2003; 114(1): 51-67.
17. Lansdorp PM, Verwoerd NP, van de Rijke FM, Drag-
owska V, Little MT, Dirks RW, Raap AK, Tanke HJ. 
Heterogeneity in telomere length of human chromo-
somes. Hum Mol Genet. 1996; 5(5): 685-691.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out 
procedure for extracting DNA from human nucleated 
cells. Nucleic Acids Res. 1988; 16(3): 1215.
19. Kogan SC, Doherty M, Gitschier A. An improved 
method for prenatal diagnosis of genetic diseases by 
analysis of amplified DNA sequences. Application to 
hemophilia A. N Engl J Med. 1987; 317(16): 985-990.
20. Simoni M, Bakker E, Krausz C. EAA/EMQN best prac-
tice guidelines for molecular diagnosis of Y-chromo-
somal microdeletions. State of art 2004. Int J Androl. 
2004; 27(4): 240-249.
21. Arnedo N, Nogués C, Bosch M, Templado C. Mitotic 
and meiotic behavior of a naturally transmitted ring Y 
chromosome: reproductive risk evaluation. Hum Re-
prod. 2005; 20(2): 462-468.
22. Tyler Smith C. Chromosome Y: General and Special 
Features. Encyclopedia of Life Sciences. (John Wiley 
& Sons, Ltd.) 2005 (www.els.net).
23. Bettio D, Venci A, Rizzi N, Negri L, Levi Setti P. Clini-
cal and molecular cytogenetic studies in three infertile 
patients with mosaic rearranged Y chromosome Hum 
Reprod. 2006; 21(4): 972-975.
24. Quilter CR, Nathwani N, Conway GS, Stanhope R, 
Ralph D, Bahadur G, Serhal P, Taylor K, Delhanty JDA. 
A comparative study between infertile males and pa-
tients with Turner syndrome to determine the influence 
of sex chromosome mosaicism and the breakpoints of 
structural abnormal Y chromosomes on phenotypic sex. 
J Med Genet. 2002; 39(12): e80.
25. Juul A. Serum levels of insulin-like growth factor I and 
its binding proteins in health and disease. Growth Horm 
IGF Res. 2003; 13(4): 113-170.
Unauthenticated
Download Date | 3/8/18 2:36 PM
